Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Rare Presentation of Parsonage-Turner Syndrome Post Tdap Vaccination: A Case Report.

Created on 30 Aug 2026

Authors

Matthew Jervis, Anastasie Dunn-Pirio

Published in

Cureus. Volume 18. Issue 7. Pages e113667. Epub Jul 30, 2026.

Abstract

Parsonage-Turner Syndrome (PTS) is a rare disorder of the brachial plexus typically characterized by acute shoulder and/or upper extremity pain, followed by muscle weakness. Though the specific etiology of PTS is unclear, numerous associations are cited in the literature, including after routine vaccinations. A previously healthy 22-year-old male developed subacute left upper extremity weakness and numbness < 24 hours following a routine Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) booster vaccination, later evolving into diffuse weakness and sharp shoulder pain. Electromyography (EMG) findings were suggestive of early PTS, and subsequent magnetic resonance imaging (MRI) of the brachial plexus confirmed mild inflammatory changes consistent with brachial plexitis. Over several months, the patient showed clinical improvement with conservative management. This case highlights a rare presentation of post-vaccination PTS, emphasizing the need for early recognition and supportive management. Although rare, clinicians should consider PTS in patients presenting with acute-onset upper extremity pain and weakness following vaccination.

PMID:
42668845
Bibliographic data and abstract were imported from PubMed on 30 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement